title: Long term infliximab treatment for severe psoriatic arthritis: evidence of sustained clinical and radiographic response.
authors.forename: F
authors.initials: F
authors.lastname: Rinaldi
authors.forename: G
authors.initials: G
authors.lastname: Provenzano
authors.forename: A
authors.initials: A
authors.lastname: Termini
authors.forename: M
authors.initials: M
authors.lastname: Spinello
authors.forename: F
authors.initials: F
authors.lastname: La Seta
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D015535:Arthritis, Psoriatic / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D000069285:Infliximab; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab; D008727:Methotrexate